|
| Press Releases |
|
 |
|
| Friday, March 21, 2025 |
|
|
Sino Biopharm (1177.HK) Announces 2024 Annual Results |
| Sino Biopharmaceutical Limited ('Sino Biopharm' or the 'Company', together with its subsidiaries, the 'Group') (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2024. more info >> |
|
| Wednesday, August 14, 2024 |
|
|
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results |
| Sino Biopharmaceutical Limited (?Sino Biopharmaceutical? or the ?Company?, together with its subsidiaries, the ?Group?) (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2024 (the ?Period?). more info >> |
|
| Friday, March 29, 2024 |
|
|
Sino Biopharm (1177.HK) Announces 2023 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2023. more info >> |
|
| Friday, August 25, 2023 |
|
|
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2023 (the "Period"). more info >> |
|
| Friday, March 31, 2023 |
|
|
Sino Biopharm (1177.HK) Announces 2022 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2022. more info >> |
|
| Tuesday, August 23, 2022 |
|
|
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited Interim results for the six months ended 30 June 2022 (the "Period"). more info >> |
|
| Thursday, July 22, 2021 |
|
|
Sino Biopharmaceutical Donates Cash and Supplies Valued at RMB10 Million to Support Henan for Flood Relief and Preventing Epidemic |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced the donation of cash and supplies valued at RMB10 million to support Henan for flood relief and preventing epidemic. more info >> |
|
| Monday, May 24, 2021 |
|
|
Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2021. more info >> |
|
| Tuesday, March 23, 2021 |
|
|
Sino Biopharmaceutical 2020 Net Profit Grows to RMB2.77 Billion amid Adversity |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited annual results for the year ended 31 December 2020. more info >> |
|
| Monday, December 7, 2020 |
|
|
Sino Biopharm Invests in Sinovac LS, A Leading COVID-19 Vaccine Company in China |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Group"; HKEX: 1177) has announced the investment of US$515 million in Sinovac Life Sciences Co., Ltd. ("Sinovac LS", previously known as Sinovac Research and Development Co., Ltd.), which will be funded by internal resources of the Group and result in a 15.03% equity interest in Sinovac LS. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Jiangsu Horizon Chain Supermarket, a Supermarket and Convenience Store Chain Store Operator, Announces Its Global Offering and Listing of H Shares on the Main Board of the Hong Kong Stock Exchange 
Mar 22, 2025 16:30 HKT/SGT
|
|
|
Q2 Metals Intercepts 179.6 Metres of Continuous Spodumene Pegmatite in Large Step-Out at the Cisco Lithium Project in Quebec, Canada
Mar 22, 2025 02:40 HKT/SGT
|
|
|
Raya Lebih Bermakna: Spritzer Sparkling's Raya 2025 Brings Fans Closer to Family and Stars
Mar 22, 2025 01:54 HKT/SGT
|
|
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum
Mar 21, 2025 23:00 HKT/SGT
|
|
|
Sino Biopharm (1177.HK) Announces 2024 Annual Results
Mar 21, 2025 22:15 HKT/SGT
|
|
|
Summit Group Holds Iftar in Singapore for About 200 Migrant Workers, Including Bangladeshis
Mar 21, 2025 19:00 HKT/SGT
|
|
|
The 33rd China International Bicycle Fair 2025 Set to Grandly Open
Mar 21, 2025 17:00 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Receives Additional Orders for Three Methanol-Fueled RORO Cargo Ships
Mar 21, 2025 17:48 JST
|
|
|
Xforce HEV Model Premieres in Thailand
Mar 21, 2025 16:09 JST
|
|
|
CTF Life Title-sponsors: 'Fencing Plus' Training Programme by Kai Tak Sports Initiative
Mar 21, 2025 12:01 HKT/SGT
|
|
|
The Executive Centre Expands Its Premium Portfolio in Singapore With a New Centre at Ocean Financial Centre
Mar 21, 2025 10:00 HKT/SGT
|
|
|
ULVAC Developing Next-Generation Dilution Refrigerator for Quantum Computing by 2026
Mar 21, 2025 10:30 JST
|
|
|
TRENDE Secures JPY 1.07 Billion Investment to Expand Renewable Energy Initiatives and Strategic Partnerships
Mar 21, 2025 07:00 HKT/SGT
|
|
|
GA-ASI Achieves EMAR/FR 145 Maintenance Organization Approval for MQ-9A and MQ-9B Platforms
Mar 21, 2025 01:00 HKT/SGT
|
|
|
Graphene Manufacturing Group Ltd. Announces Closing of Bought Deal Financing
Mar 20, 2025 23:09 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
